SelenBio on Netcapital

antibacterial technology for a wide variety of use cases

Raise to date: $147,972

Reporting Date: 05/03/2020

Key Stats

Minimum Raise

$10,000

Maximum Raise

$1,070,000

Likelihood of Max Unlikely
Start Date

10/03/2019

Stop Date

04/28/2020

Days Remaining

Closed

Security Type

Common Stock

Investment Minimum

$4

Deal Type

No Review


Investment Summary

Status

Confirmed Closed

# of Investors

Not Known

% of Minimum Raised

1,480%

% of Maximum Raised

14%

Dollars Per Day to Reach Max

N/A

DPD* Committed

$711

DPD* Category

$0

DPD* All Companies

$923

Kingscrowd Momentum

$147,972

Total Dollars Raised

Commitments

Weekly Commitments ($)
Aggregate Commitments ($)

SEC Filing Data from Kingscrowd

SelenBio, a biotechnology company with a post-money valuation of $20.7 million, is raising funds on NetCapital. The company develops an antibacterial technology that prevents the formation of biofilm in dental, medical, industrial, and consumer applications. SelenBio uses a unique selenium-based compound, SELDOX, to keep the applications infection-free. The company was founded by Kenny Gallagher and Karl Doenges. The proceeds of the current crowdfunding round, with a minimum target of $10,000 and a maximum target of $1,070,000, will be used for research & development, operations, completion of current projects, sales & marketing, and compensation for managers. SelenBio is working on multiple projects with excellent traction and has already received the FDA approval for SELDOX.

Create your first portfolio
WELCOME TO YOUR OWN INVESTMENTS PORTFOLIO ON KINGSCROWD.

Now you can track all of your startup investments in one place utilizing our state-of-the-art portfolio tracker tools. To begin, create your first portfolio below.

Add to portfolio
Add SelenBio on Netcapital
Follow company
Follow SelenBio on Netcapital
INVEST NOW

Get access to the first and only premium analytics and rating platform that enables informed startup investments.

Become an Informed Investor